Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients

Detection of Plasma DNA by Allelotyping in Non Small Cell and Small Cell Lung Cancer Patients. Evolution During Treatment and Follow-up.

The majority of lung cancer patients have a tumor-derived genetic alteration in circulating plasma DNA that could be exploited as a diagnostic tool. The aim of this study is to evaluate if plasma DNA can be used as a valuable non invasive test to monitor disease progression without assessing the tumor.

Inclusion Criteria:

• Presence of lung tumor to use fiberoscopy or surgical intervention for diagnosis.
• No lung instability.
• Individuals give all informed consent